Kotra Industries Bhd (XKLS:0002) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0002 Kotra Industries Bhd XKLS:0002
83 GF Score
Price RM3.70
GF Value RM4.34
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Kotra Industries Bhd Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

XKLS:0002
83GF Score
Kotra Industries Bhd XKLS:0002
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?

Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued. The current stock price of RM3.70 is trading 14.7% below its estimated GF Value™ of RM4.34. GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0002:

  • Interest Received:
  • GF Value™: RM4.34 vs. price of RM3.70 (14.7% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kotra Industries Bhd Business Description

Address Jalan TTC 12, No. 1, 2 & 3, Cheng Industrial Estate, Melaka, MYS, 75250
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
83GF Score

Get the complete analysis for XKLS:0002

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.70
Price
RM4.34
GF Value